Navigation Links
Adult and Adolescent Vaccines Market to 2018 Report - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
Date:6/6/2013

DUBLIN, June 6, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/32gm2w/adult_and) has announced the addition of the "Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


Protection from Cervical Cancer Hindered by Market Rivalry

Pharmaceutical giants GlaxoSmithKline (GSK) and Merck are fighting it out in the vaccination market, as countries pick sides in their cervical cancer vaccination programs, states a new report by research and consulting firm GBI Research.

The new report* shows that existing cervical cancer vaccines, GSK's Cervarix and Merck's Gardasil, are competing against each other for valuable market share in a highly rewarding market segment.

The global vaccines market is highly fragmented, and national health authorities can have dramatically differing requirements and regulations, delaying the introduction of some vaccines across global markets. The inclusion of any vaccine into a national immunization schedule promises widespread immunization coverage for the population, and increases the potential for huge revenues for the company.

Despite the European Commission approving Cervarix in 2007, the vaccine was only approved in the US two years later, resulting in a monopoly for competing vaccine Gardasil in the US during this period. Gardasil has also now been approved for use in men to prevent genital warts and anal cancer caused due to human papillomavirus infection, providing the drug with a further strength against competing products.

Cervical cancer vaccines are essentially prophylactic vaccines that prevent against the infection of HPV, which is responsible for 70% of cervical cancer cases in women. HPV vaccines have been found to reduce the incidence of cervical cancer, an area with a high disease burden, and various countries are consequently offering vaccinations for all young girls as a widespread preventative measure. In addition to this, the Advisory Committee on Immunization Practices (ACIP) now also recommends that all 11-12 year old males get vaccinated against HPV, as this will decrease the risk for male genital warts, and reduce the potential for HPV transmission in the future.

Various other high-burden diseases are still urgently in need of vaccines, with HIV/AIDS, malaria and tuberculosis representing some of the most pressing health concerns of many governments across the world. HPV vaccines may herald a new era of preventative medicine, as major diseases are stopped before they ever start.

The Human Papillomavirus (HPV) vaccines market for adults and adolescents across the US, Germany, Spain, Italy, France, the UK and Japan is expected to grow from a strong value of US$1.8 billion in 2011 to US$2.2 billion in 2018. Revenue from HPV vaccines peaked in 2008, following the initiation of nationwide immunization programs, but the anticipated treatment of all children and the high cost of HPV vaccinations, at over US$100 per person, secures this market's future."

Companies Mentioned

- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi

For more information visit http://www.researchandmarkets.com/research/32gm2w/adult_and

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716


Sector: Healthcare and Medical Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Washington State Medical Association (WSMA) Urges Adults to Get Recommended Immunizations
3. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
4. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
5. Social Norms, Life Changes and Increasing Pressures Contribute to Substance Abuse Among Adult Women
6. Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients with Eosinophilic Esophagitis
7. Daily Cocoa Flavanol Consumption Shown to Improve Cognitive Function in Older Adults
8. Zarbees Introduces a New Extra Strength Line of Natural Cough Products for Adults and Children 12+ in Time for Cough and Cold Season
9. RNL BIO, a South Korean adult stem cell firm, introduces its autologous stem cell therapeutics in Turkey to treat patients with various intractable diseases
10. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
11. Weight Loss Surgery May Be as Equally Beneficial for Teens as for Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... SINGAPORE , July 27, 2017  Radium Medical Aesthetics, a ... LASEMD, designed to delay aging by effectively addressing several skin conditions ... the skin to become rougher and more fragile. The skin becomes ... the unavoidable exposure to the harmful UV rays from the sun ... hyperpigmentation. ...
(Date:7/26/2017)... YORK , July 26, 2017 The ... Annual Prix Galien USA Award Nominees. ... the Prix Galien Award recognizes outstanding biomedical and technology product ... To qualify, each candidate must be U.S. ... last five years and demonstrate tremendous potential to impact human ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, ... communities throughout the greater DC region, is inaugurating a “New Leash On Life” ... animals and training them to be companions for veterans in need. , The ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning services to communities in east Texas, is launching a regional ... Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has ...
(Date:8/18/2017)... Saint John, IN (PRWEB) , ... August 18, 2017 , ... ... services to communities in northwest Indiana, is campaigning in support of Campagna Academy in ... Formerly referred to as the “Hoosier Boys’ Town of Indiana,” Campagna Academy is a ...
(Date:8/18/2017)... ... ... The Golseth Agency, a Texas based insurance management and financial planning assistance provider ... organized to provide support to Christina Upchurch and her two children after the loss ... returned from out of town to find her husband passed away and their home ...
Breaking Medicine News(10 mins):